Medicines Reconciliation at an Intensive Care Unit
1 other identifier
interventional
50
1 country
1
Brief Summary
This study evaluates the effect of performing medicines reconciliation on patients admitted to an intensive care unit. Half of the patients will receive a medicines reconciliation at the intensive care unit. The other half will not. All included patients will receive medicines reconciliation after transfer to the ward.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2017
CompletedFirst Submitted
Initial submission to the registry
May 22, 2017
CompletedFirst Posted
Study publicly available on registry
June 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJuly 11, 2017
June 1, 2017
5 months
May 22, 2017
July 7, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with at least one discrepancy between medications listed on hospital chart and medications used at home before hospital admittance
Medications listed on the medication chart were recorded on a predefined form, this included information on dosage form, strength, dosage and administration time for each drug. The pharmacist performed medicines reconciliation either by interviewing the patient or by gathering information from other sources as the patient's general practitioner, next-to-kin or if relevant nursing home. Any deviations between the information from the medication chart and information obtained during medicines reconciliation was defined as a discrepancy.
Medicines reconciliation is performed at randomisation and within 48 hours after transmission to the ward, assessed up to 28 days after randomisation
Secondary Outcomes (1)
Retrospective evaluation on the clinical relevance of the observed medical discrepancies
Retrospectively, based on the information gathered from the day of randomisation up until 28 days after randomisation
Study Arms (2)
Intervention group
EXPERIMENTALReceive medication reconciliation at the ICU, pluss medication reconciliation at the ward
Control group
OTHERNo intervention at the ICU, medication reconciliation at the ward
Interventions
Medication reconciliation performed according to Integrated Medicines Management model
Medication reconciliation performed according to Integrated Medicines Management model
Eligibility Criteria
You may qualify if:
- belonging to the hospitals intake area
- written informed concent by the patient or his/her next to kin
You may not qualify if:
- Patients without next to kin
- Not Norwegian speaking, in need of a translator
- medication reconciliation performed earlier
- Patients with Guillain-Barre or Myasthenia Gravis, due to long expectancy of stay
- Short life expectancy, decided in cooperation with the physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akershus university Hospital
Lørenskog, Akershus, Norway
Study Officials
- PRINCIPAL INVESTIGATOR
Silje E Oernes, PhD
Hospital Pharmacy Enterprise, South Eastern Norway
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- The care provider performing medicines reconciliation at ward is semimasked. The masking might be broken if the patients tells if he/she has been interviewed earlier in the study
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical pharmacist, Ph.d
Study Record Dates
First Submitted
May 22, 2017
First Posted
June 2, 2017
Study Start
February 6, 2017
Primary Completion
July 6, 2017
Study Completion
October 1, 2017
Last Updated
July 11, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share